MBX NASDAQ
MBX Biosciences, Inc. Common Stock
1W: -4.2%
1M: -6.2%
3M: -16.3%
YTD: +64.6%
1Y: +211.8%
$52.97
+2.68 (+5.33%)
After Hours: $54.59 (+1.62, +3.05%)
Weekly Expected Move ±8.3%
$40
$44
$48
$53
$57
Credit Risk of going bust: lower than 78% of companies Debt: 0.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down more than 99.9%), MBX Biosciences, Inc. Common Stock would be worth roughly what it owes.
Total debt $3.3M against a stock market value of $2.42B.
Distance to default 9.14 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.7M (short-term plus half of long-term), stock volatility 76.9%; Altman Z'' 18.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.01 (down more than 99.9%), MBX Biosciences, Inc. Common Stock would be worth roughly what it owes.
Total debt $3.3M against a stock market value of $2.42B.
Distance to default 9.14 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.7M (short-term plus half of long-term), stock volatility 76.9%; Altman Z'' 18.59. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-09-26
Earliest Filing
2026-02-27
Latest Filing
partner: 3
supplier: 1
Counterparties (Filed by MBX)
4 relationshipsCompanies named in MBX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| 5 Burlington Woods, LLC | — | supplier | Landlord in lease agreement for office and laboratory space | 2026-02-27 | View |
| CBRE, Inc. | CBRE | partner | Broker representing the Landlord | 2026-02-27 | View |
| Cushman & Wakefield | CWK | partner | Broker representing the Tenant | 2026-02-27 | View |
| Jefferies LLC | JEF | partner | Underwriter representative for the public offering | 2025-09-26 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-22 | Officer/Director Change; Exhibits | View | |
| 2026-08-27 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-06 | Earnings Release; Regulation FD; Other Events; Exhibits | View | |
| 2026-07-13 | Officer/Director Change | View | |
| 2026-06-12 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-05 | Officer/Director Change; Shareholder Vote | View | |
| 2026-05-11 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-27 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2026-02-05 | Other Events | View | |
| 2026-01-22 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Sta | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-09-26 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-09-22 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-04 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-16 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR